Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

To assess whether T1 relaxation time of tumors may be used to assess response to bevacizumab anti-angiogenic therapy.12 female nude mice bearing subcutaneous SKOV3ip1-LC ovarian tumors were administered bevacizumab (6.25ug/g, n=6) or PBS (control, n=6) therapy twice a week for two weeks. T1 maps of...

Full description

Bibliographic Details
Main Authors: Murali K Ravoori, Masato Nishimura, Sheela P Singh, Chunhua Lu, Lin Han, Brian P Hobbs, Sunila Pradeep, Hyun J Choi, James A Bankson, Anil K Sood, Vikas Kundra
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4476738?pdf=render

Internet

http://europepmc.org/articles/PMC4476738?pdf=render

Similar Items